Group 1 - Apple's film "F1" has earned over $55 million domestically and over $88 million internationally, totaling $144 million globally since its release [1] - The film outperformed competitors, including Universal Pictures' "How to Train Your Dragon" and Disney's "Elio," securing the top position at the box office [1] - Apple heavily promoted the film, offering discounted tickets to iPhone users and utilizing Apple Maps for promotional purposes [2] Group 2 - Apple's original film production is a newer division, still catching up to major studios like Paramount Pictures and Sony Pictures [4] - The company's streaming service has seen some success but remains behind competitors like Netflix [5] - The success of "F1" is seen as a relief for Apple following a lackluster Worldwide Developers Conference, where analysts were underwhelmed by new software announcements [5][6] Group 3 - Apple CEO Tim Cook emphasized the company's commitment to storytelling and the desire to make the film business successful [6] - There are questions regarding Apple's long-term strategy for theatrical releases, whether it is a marketing play for iPhones or an effort to diversify as iPhone sales plateau [5]

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of deceptive practices related to the promotion and sale of illegitimate versions of the drug Wegovy, resulting in a significant drop in stock price following the termination of its partnership with Novo Nordisk [1][3]. Group 1: Lawsuit Details - The class action lawsuit, Sookdeo v. Hims & Hers Health, Inc., involves allegations that Hims & Hers and its executives violated the Securities Exchange Act of 1934 [1]. - The lawsuit claims that Hims & Hers engaged in deceptive promotion and selling of illegitimate versions of Wegovy, which jeopardized patient safety [2]. - Following the announcement of the termination of the partnership with Novo Nordisk on June 23, 2025, Hims & Hers' stock price fell by more than 34% [3]. Group 2: Legal Process - Investors who purchased Hims & Hers securities during the class period (April 29, 2025, to June 23, 2025) can seek appointment as lead plaintiff in the class action lawsuit [4]. - The lead plaintiff will represent the interests of all class members and can choose a law firm to litigate the case [4]. Group 3: Company Background - Hims & Hers is a telehealth company that provides prescription medications, over-the-counter medications, and personal care products [2]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized for its success in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [5].

Core Viewpoint - TMC The Metals Company has experienced a significant increase in stock price, driven by positive market momentum and favorable analyst coverage, despite some sell-offs in the latter half of the trading week [1][2][4]. Group 1: Stock Performance - TMC's stock closed the week up 3.8%, outperforming the S&P 500 index, which rallied by 3.4% [1]. - The stock has risen 44% over the last month, largely due to bullish market sentiment and a major investment from Korea Zinc [2]. - Following Wedbush's upgrade of TMC's rating from neutral to outperform, the stock saw a significant increase in trading activity [5]. Group 2: Market Dynamics - Positive macroeconomic indicators, including potential interest rate cuts by the Federal Reserve, have contributed to a bullish market outlook [4]. - A ceasefire between Israel and Iran has also provided a favorable geopolitical backdrop, enhancing investor sentiment [4]. Group 3: Analyst Coverage - Wedbush raised its one-year price target for TMC from $6 to $11 per share, indicating a potential upside of approximately 61.5% [5]. - The positive analyst coverage has played a crucial role in boosting TMC's stock performance [5]. Group 4: Regulatory Environment - The U.S. is increasing its domestic mineral production capabilities amid geopolitical tensions with China, which may benefit TMC [6]. - TMC still faces regulatory hurdles but the overall conditions appear to be improving for the company [6].

Rocket Lab (RKLB -1.99%) stock soared this week thanks to a combination of bullish catalysts. The space-tech company's share price climbed 17.8% from the previous Friday's market close in a stretch that saw the S&P 500 index rise 3.4% and set a new record high.Strong bullish momentum shaped the broader market this week as the new ceasefire between Israel and Iran lessened geopolitical volatility and investors bet that the Federal Reserve is poised to take a more dovish stance on interest rates. Rocket Lab s ...

新华社北京6月29日电 记者手记：小小穴贴里的千年智慧 新华社记者田晓航、徐鹏航 一年一度的"冬病夏治三伏贴"又要开贴了。 记者了解到：中国中医科学院广安门医院开放贴敷门诊预约仅5天，已收到上千人次预约，预计今年要服务的患者数量将不少于去年的5万余人 次；首都医科大学附属北京中医医院自6月21日开启预约，已收到近6000人次预约。 小小三伏贴究竟有何效力？记者前往北京中医医院制剂生产车间一探究竟。 穿上鞋套和洁净服、戴上口罩和帽子走进车间，眼前，药师们正在制作"温阳化痰穴贴"。这种穴贴已连续多年作为北京市"冬病夏治三伏贴"专项 工作指定用药，供全市700余家医疗机构调剂使用。 药师在制作"温阳化痰穴贴"。新华社记者徐鹏航 摄 "一枚'温阳化痰穴贴'融合了炒芥子、细辛、百部等六味药材，每一味都有其独特功效。"北京中医医院药学部副主任肖薇如数家珍：炒芥子性 温、味辛，能温肺豁痰利气；细辛性温、味辛，擅祛风止痛、温肺化饮；百部性微温，味甘、苦，助润肺下气止咳…… 从饮片到穴贴，六味药材经过怎样的"历练"？记者穿行于各个制剂车间，观摩穴贴"出炉"的全过程： 中药饮片经检验达标后，将其粉碎成粉；将蜂蜡、蜂蜜和植物油等辅 ...

视觉 | 诺言 你叫吴宇伦，2016年拖着行李来到一座陌生的大城市，住在一间月租500元的城中村单间。白天上班， 晚上跑外卖，月底到手不过两千多块。你没什么朋友，也不常说话，日复一日，平淡无奇。 来源：盐财经 作者 | 木木 编辑 | 江江 上线当日，游戏定价33元，首发期间打折至29.04元。这个价格远低于同类互动影游（通常在52—68元 区间）。而据游戏官方透露，这款游戏至少需要卖出37万份才能回本。但仅仅上线5天，游戏销量突破 68万份，登上国区热销榜第一，全球排名一度冲进前三。 根据游戏数据平台SteamDB估算，截至6月25日，《情感反诈模拟器》已售出超68万份，全球营收约340 万美元；若按国内售价29.04元计算，总收入已接近2000万元人民币，折算下来，游戏上线期间平均每 天营收超400万元人民币。 《情感反诈模拟器》游戏截图 游戏原名叫《捞女游戏》，上线仅一天就因海啸般的舆论争议，被迫更名为《情感反诈模拟器》。 但这并没有影响它的传播速度，相反，作为一款商品，《捞女游戏》成功吃透了"情绪经济"中的"愤怒 红利"，但也暴露了"情绪经济"下的伦理困境。 爆火出圈，日赚400万 直到偶遇了一位女主 ...

智通财经6月30日电，据央视新闻报道，美国总统特朗普当地时间6月29日表示，美国对伊朗福尔多核设 施的袭击完全摧毁了目标地点。特朗普说，"现在那个地方只有几千吨的岩石，整个地方被摧毁了，伊 朗另外两个核设施也被摧毁了"。特朗普称，以色列对伊朗核设施造成了破坏，但美国造成了最后的破 坏。特朗普否认伊朗在美国发起袭击前将任何东西进行了转移。此外，参与袭击的B-2轰炸机飞行员将 去往白宫。 "现在那里只有几千吨岩石" 特朗普称已完全摧毁伊朗三处核设施 ...

智通财经6月30日电，据央视新闻，根据俄罗斯莫斯科谢列梅捷沃机场公布的消息，当地时间29日，一 架由俄罗斯莫斯科飞往加里宁格勒的客机在起飞后出现技术故障而返航，目前飞机已安全着陆。此前消 息称，返航飞机机组人员报告称，飞机在起飞后无法跟踪既定的导航参数。 俄罗斯一客机因技术故障返航 ...

申万智富投资公司投资部经理王飞介绍了基差贸易的原理与应用，指出企业可利用基差点价、延期点价 等模式优化库存管理和购销成本，更好地管理传统定价模式下的市场风险，并结合PVC等品种的实战案 例，解析了基差贸易如何帮助企业提升经营成效。 翱兰农业中国区首席风控官许沙莎梳理了套期保值的风险管理框架，针对企业生产经营中常见的市场、 外汇和信用等主要风险，建议通过完善的组织架构和量化工具进行系统防控。她特别强调了套期会计处 理的重要性，并以铁矿石和玉米的会计处理为例，展示了公允价值与现金流量套期在财务报表中的差异 化处理，为企业合规开展套保业务提供了有效实操方案。 为提升企业套期保值能力和现代企业风险管理水平，促进宁波实体经济高质量发展，6月20日，在宁波 证监局、宁波市委金融办指导下，由大连商品交易所（下称大商所）支持，宁波市证券期货业协会、宁 波上市公司协会联合申银万国期货有限公司共同主办的第5期"DCE·产业行"宁波地区大宗商品产业培训 班在宁波市举办。来自宁波证监局、宁波市委金融办相关处室和宁波地区上市公司、拟上市公司、"专 精特新"和大宗贸易商等企业的100余名代表参加培训。 申银万国期货有限公司副总经理、首席 ...

20多家信托公司落地超百单产品——这是特殊需要信托最新的阶段性成绩，也是信托公司探路资产服务 信托的缩影。而服务信托若要进入千家万户，还有多个问题等待破解。 资产服务信托在信托业务"三分类"中排在首位，是监管部门倡导信托公司展业的重要业务类型。该类信 托主要包括财富管理服务信托、行政管理服务信托、资产证券化服务信托和风险处置服务信托等。其 中，特殊需要信托属于财富管理服务信托项下。 信托公司积极转战服务信托的效果已有数据体现。近期公布的数据显示，2024年新成立信托产品6.74万 只，其中，资产服务信托产品4.73万只，占比超七成。因此，2024年信托资产实现高增长，不只是简单 的规模扩张，还有业务转型的结构优化。 事实上，以特殊需要信托为代表的服务信托，也是被寄予厚望的信托本源业务。未来该项业务的发展壮 大，不仅能重塑中国信托业态，也将发挥信托制度的更大社会价值。 信托是以受托人为核心的法律关系和制度安排，信托架构具有"资产隔离"的显著特征。根据成熟市场经 验，如果服务信托发展得好，"人人懂信托、学会用信托"，信托制度在社会治理、家庭事务、公益慈善 等领域就会有广阔应用空间。这意味着，以往只服务于高净值人群 ...